Former Dutch regulator joins PAREXEL

PRLog (Press Release) – PAREXEL International (Boston, Massachusetts) has appointed Dr Hans Van Bronswijk as principal consultant in PAREXEL Consulting’s European drug development practice. He will be responsible for advising clients on all aspects of clinical development and regulatory affairs. Dr Van Bronswijk was head of clinical assessment for the Dutch Medicines Evaluation Board for nine years and represented the Netherlands on the European Medicines Agency’s Committee for Medicinal Products for Human Use for six years. He has also held various positions with Novartis, most recently as global head of regulatory affairs for the transplantation and immunology business unit. Prior to that, he was a medical doctor specialising in transplant medicine and renal diseases. Article submitted by www.jobs4dd.com, a specialist onlie recruitment site for the clinical trial and clinical research sectors.